Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Preclinical assessment of endovascular hydrogel embolization for the treatment of vascular disorders

FY 2020-21

Summary
Recent advances in technology has furthered our ability to treat various blood vessel diseases through minimally invasive procedures, as opposed to open surgery. One such treatment is endovascular embolization, where through a blood vessel puncture, catheters can be navigated to various parts of the body, and embolic material can be delivered to seal the diseased blood vessels. This is used to treat cerebral aneurysms, bleeding, or abnormal vessels. However, there are still limitations in terms of the safety and efficacy of this treatment, and those usually relate to limitations of the embolic material used. Current materials such as coils or liquids may not fully seal the blood vessel abnormality, leading to incomplete treatment, or be difficult to fully control, causing off target embolization leading to stroke. Finding better embolization materials and methods would improve the ability to treat a wide range of diseases safely and effectively without requiring open surgery. One possibility is through hydrogels, a class of materials which may be modified to meet the needs of an ideal embolization agent. We are investigating the use of hydrogels as an embolization agent, using biologically inert, light sensitive, liquid formulas. Once injected through the catheter, it fills the blood vessel and then solidifies through a crosslinking process. The crosslinking process is driven by a light source embedded within the catheter, which can be adjusted to give varying degrees of hydrogel viscosity. This allows for better control and improved filling of the target vessel, hopefully leading to better treatment outcomes. The goal of our study is to test and finetune this technology, through 3D printed models and animal models of various diseases, including aneurysms, blood vessels, and tumors.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
439373
Name
Ku Jerry C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Preclinical assessment of endovascular hydrogel embolization for the treatment of vascular disorders
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Arteriovenous Malformation; Biomedical Engineering; Cerebral Aneurysm; Embolization; Endovascular; Hemorrhagic Stroke; Hydrogel; Interventional Neuroradiology; Material Science; Tumour
Abstract
Recent advances in technology has furthered our ability to treat various blood vessel diseases through minimally invasive procedures, as opposed to open surgery. One such treatment is endovascular embolization, where through a blood vessel puncture, catheters can be navigated to various parts of the body, and embolic material can be delivered to seal the diseased blood vessels. This is used to treat cerebral aneurysms, bleeding, or abnormal vessels. However, there are still limitations in terms of the safety and efficacy of this treatment, and those usually relate to limitations of the embolic material used. Current materials such as coils or liquids may not fully seal the blood vessel abnormality, leading to incomplete treatment, or be difficult to fully control, causing off target embolization leading to stroke. Finding better embolization materials and methods would improve the ability to treat a wide range of diseases safely and effectively without requiring open surgery. One possibility is through hydrogels, a class of materials which may be modified to meet the needs of an ideal embolization agent. We are investigating the use of hydrogels as an embolization agent, using biologically inert, light sensitive, liquid formulas. Once injected through the catheter, it fills the blood vessel and then solidifies through a crosslinking process. The crosslinking process is driven by a light source embedded within the catheter, which can be adjusted to give varying degrees of hydrogel viscosity. This allows for better control and improved filling of the target vessel, hopefully leading to better treatment outcomes. The goal of our study is to test and finetune this technology, through 3D printed models and animal models of various diseases, including aneurysms, blood vessels, and tumors.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ku, Jerry C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~